CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleRevenue is $977.78M, above the global median of $548.88M
- FinancialsAltman Z-Score 1.43: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.18%Below 5Y avg (1.35%)
Annual Rate
CNY 0.06Paid unknown
Payout Ratio
36.9%Sustainable
Payback Period
86.5 yr
Last Ex-Dividend
Jun 23, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.65BCNY991.84M · vs all stocks (USD)
Trailing P/E
31.20xRevenue (TTM)
6.56BCNY977.78M · vs all stocks (USD)
Profit Margin
3.28%Beta
0.0740xvs all stocks
52-Week Change
-15.12%vs all stocks
Forward Annual Dividend Yield
1.18%vs all stocks
Market Capitalization
6.65BCNY991.84M · vs all stocks (USD)
Enterprise Value
4.45BCNY664.30M · vs all stocks (USD)
Trailing P/E
31.20xPrice to Sales (TTM)
1.02xPrice to Book (MRQ)
1.21xEnterprise to Revenue
0.6790xEnterprise to EBITDA
7.03xGross Margin
38.43%Profit Margin
3.28%Operating Margin
-0.39%Return on Assets (TTM)
0.75%Return on Equity (TTM)
2.81%Revenue (TTM)
6.56BCNY977.78M · vs all stocks (USD)
Revenue per Share (TTM)
4.56CNYUpdated Sep 18, 2026Quarterly Revenue Growth
-30.40%Gross Profit (TTM)
2.20BCNY327.74M · vs all stocks (USD)
EBITDA (TTM)
503.82MCNY75.15M · vs all stocks (USD)
Net Income (TTM)
214.76MCNY32.03M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-38.40%Operating Cash Flow (TTM)
927.30MCNY138.32M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
418.56MCNY62.43M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0600CNYUpdated Sep 18, 2026Forward Annual Dividend Yield
1.18%vs all stocks
Trailing Annual Dividend Rate
0.0550CNYUpdated Sep 18, 2026Trailing Annual Dividend Yield
1.18%vs all stocks
5-Year Average Dividend Yield
1.35%vs all stocks
Payout Ratio
36.91%Minority Interest (Equity)
139.40MCNYFY2025 · Dec 31, 2025Revenue
7.07BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
4.44BCNYFY2025 · Dec 31, 2025Gross Profit
2.64BCNYFY2025 · Dec 31, 2025Operating Income
498.81MCNY74.40M · vs all stocks (USD)
Pre-tax Income
305.26MCNYFY2025 · Dec 31, 2025Income Tax Expense
87.43MCNYFY2025 · Dec 31, 2025Net Income
217.83MCNYFY2025 · Dec 31, 2025EBIT
354.43MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.07BCNYFY2025 · Dec 31, 2025Research & Development
172.27MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
1.41BCNYFY2025 · Dec 31, 2025Other Operating Expenses
114.11MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
90.67MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
49.16MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1800CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1800CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.44BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.44BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
217.83MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
42.24MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
511.03MCNYFY2025 · Dec 31, 2025Free Cash Flow
418.80MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.85BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
217.83MCNYFY2025 · Dec 31, 2025Other Non-cash Items
100.20MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
101.58MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
91.42MCNYFY2025 · Dec 31, 2025Capital Expenditures
-92.23MCNYFY2025 · Dec 31, 2025Purchase of Investments
-50.29MCNYFY2025 · Dec 31, 2025Sale of Investments
53.16MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-89.37MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
2.85BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-2.33BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-196.90MCNYFY2025 · Dec 31, 2025Other Financing Charges
-555.85MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-238.95MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.43BSharesUpdated Sep 18, 2026Float Shares
579.50MSharesUpdated Sep 18, 2026% Held by Insiders
61.23%vs all stocks
% Held by Institutions
1.09%vs all stocks
Total Cash (MRQ)
4.17BCNY621.95M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.92CNYUpdated Sep 18, 2026Total Debt (MRQ)
1.84BCNY274.57M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3257xCurrent Ratio (MRQ)
1.14xBook Value per Share (MRQ)
3.88CNYUpdated Sep 18, 2026Total Assets
12.89BCNY1.92B · vs all stocks (USD)
Total Current Assets
7.53BCNYFY2025 · Dec 31, 2025Total Liabilities
7.22BCNYFY2025 · Dec 31, 2025Total Non-current Assets
5.36BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
655.91MCNYFY2025 · Dec 31, 2025Total Current Liabilities
6.56BCNYFY2025 · Dec 31, 2025Cash
2.89BCNYFY2025 · Dec 31, 2025Cash Equivalents
713.41MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.60BCNYFY2025 · Dec 31, 2025Other Short-term Investments
350.62KCNYFY2025 · Dec 31, 2025Accounts Receivable
1.73BCNYFY2025 · Dec 31, 2025Inventory
1.18BCNYFY2025 · Dec 31, 2025Accounts Payable
2.86BCNYFY2025 · Dec 31, 2025Short-term Debt
1.97BCNYFY2025 · Dec 31, 2025Other Current Liabilities
108.17MCNYFY2025 · Dec 31, 2025Long-term Debt
174.42MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
261.56MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.43BCNYFY2025 · Dec 31, 2025Retained Earnings
1.37BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
5.67BCNY845.63M · vs all stocks (USD)
Treasury Stock
2.47MCNYFY2025 · Dec 31, 202552-Week Low
4.09CNYUpdated Sep 18, 202652-Week High
5.93CNYUpdated Sep 18, 202652-Week Change
-15.12%vs all stocks
Beta
0.0740xvs all stocks
50-Day MA
4.80CNYUpdated Sep 18, 2026200-Day MA
4.99CNYUpdated Sep 18, 2026Avg 10-Day Volume
9.84MSharesUpdated Sep 18, 2026Avg 30-Day Volume
22.27MSharesUpdated Sep 18, 2026Diluted EPS (TTM)
0.1500CNYUpdated Sep 18, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash Backing With OCF Coverage And Cash Near Total Debt
Cash on hand covers most or all of its total debt, and cash flow matches reported earnings.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.43: grey zoneSignificant
Altman Z-Score: 1.43
High earnings qualityNotable
Earnings Quality Score: 0.55
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Revenue is $977.78M, above the global median of $548.88MNotable
Revenue (USD): 977,777,221.386Global Median: 548,883,780.48
Levered free cash flow is $62.43M, above the global median of $18.73MNotable
Levered free cash flow (USD): 62,431,679.313Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Vor Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Hunan Er-Kang Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Edan Instruments Inc.
Tier 1ProductionApproval-Gated PipelineRule
Cisen Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Janux Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Chengdu Kanghua Biological Products Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Pacira BioSciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jinghua Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Anhui Wanbang Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Wuhan Huakang Century Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Friedrich Vorwerk Group SE
1 interpretationCash Backing With OCF Coverage And Cash Near Total Debt
Vontobel Holding AG
1 interpretationCash Backing With OCF Coverage And Cash Near Total Debt
Kotak Mahindra Bank Ltd.
1 interpretationCash Backing With OCF Coverage And Cash Near Total Debt